Cardiff Oncology, Inc. - Common Stock (NQ:CRDF)

1.120 -0.060 (-5.08%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cardiff Oncology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 01, 2024

Pre-market stock movers are worth checking on Friday as investors prepare for the last day of trading this week with all of the latest news!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 29, 2024

Via Benzinga

Recap: Cardiff Oncology Q4 Earnings ↗

February 29, 2024

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

Cardiff Oncology Earnings Preview ↗

February 28, 2024

Via Benzinga

Earnings Preview: Cardiff Oncology ↗

November 01, 2023

Via Benzinga

Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference

February 26, 2024

From Cardiff Oncology, Inc.

Via GlobeNewswire

Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update

February 22, 2024

From Cardiff Oncology, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 14, 2024

Via Benzinga

Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

December 20, 2023

The Dow Jones index closed higher by around 250 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Rising Number of Studies to Develop Novel Therapies For Pancreatic Ductal Adenocarcinoma (PDAC) Intensely Increasing

October 23, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NYSE:LLY),(NYSE:ABBV),(NASDAQ:LIPO) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 27, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 27, 2023

Via Benzinga

Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket ↗

September 27, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 27, 2023

Pre-market stock movers are worth keeping track of and we're helping with the biggest winners and losers for Wednesday morning!

Via InvestorPlace

Why Cardiff Oncology Stock Is Rising After Hours ↗

September 26, 2023

Cardiff Oncology, Inc. (NASDAQ: CRDF) shares are trading higher Tuesday after-hours after the company announced clinical data in pancreatic cancer and small cell lung cancer, including single-agent...

Via Benzinga

Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year’s End

August 09, 2023

EQNX::TICKER_START (NYSE:PTN),(NASDAQ:CRDF),(NASDAQ:BDRX),(NASDAQ:DRUG),(NYSE:LLY) EQNX::TICKER_END

Via FinancialNewsMedia

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 08, 2023

Via Benzinga

Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 08, 2023

Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser...

Via Benzinga

Why Hims & Hers Health Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket ↗

August 08, 2023

Gainers Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares surged 83.5% to $0.1648 in pre-market trading after falling over 25% on Monday. The company recently announced its plans to reduce the...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 28, 2023

Via Benzinga

Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical Trials

January 19, 2023

EQNX::TICKER_START (NASDAQ:TCBP),(NASDAQ:CRDF),(NASDAQ:CYAD),(NASDAQ:RIGL),(NASDAQ:AZN) EQNX::TICKER_END

Via FinancialNewsMedia

Global Breast Cancer Market Size Projected To Hit $70 Billion in Revenues By 2030

May 05, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:BMY),(NASDAQ:NNOX),(NASDAQ:SNGX),(NASDAQ:CRDF) EQNX::TICKER_END

Via FinancialNewsMedia

Clear Channel Outdoor And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗

October 12, 2022

US gold futures traded lower this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Hoth Therapeutics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying ↗

September 20, 2022

The Dow Jones jumped by around 197 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around...

Via Benzinga

Rising Incidence of Pancreatic Cancer Driving Demand for Advanced Treatment Therapies

November 07, 2022

Palm Beach, FL – November 7, 2022 – FinancialNewsMedia.com News Commentary – While there is no cure for pancreatic cancer in the pancreatic cancer treatment market, new treatment options abound, and...

Via FinancialNewsMedia

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 19, 2022

Via Benzinga

Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028

October 12, 2022

Palm Beach, FL –– October 12, 2022 – FinancialNewsMedia.com News Commentary – The COVID pandemic has not only had a negative effect on most markets but it has also spurred growth in several worldwide...

Via FinancialNewsMedia

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday ↗

September 14, 2022

Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.